SCHEMBL4346540

SCHEMBL4346540

COC(=O)c1cccc(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
TP53 P04637 3/20 0.49
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.45
CYSLTR1 Q9Y271 1/20 0.45
TSHR P16473 1/20 0.44
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
PRSS1 P07477 1/20 0.44
ACR P10323 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2982620 0.88 ESR1 (0.42) L3MBTL1SMN1; SMN2TP53NPC1MEN1
SCHEMBL341880 0.84 KMT2A (0.53) L3MBTL1SMN1; SMN2RAB9ANPC1MEN1
SCHEMBL2989104 0.84 AKR1C3 (0.53) RAB9ANPC1KMT2APOLBMRGPRX4
SCHEMBL6625609 0.84 KDM4E (0.44) L3MBTL1ALDH1A1TSHRPOLBLMNA
SCHEMBL18304558 0.84 KDM4E (0.44) L3MBTL1ALDH1A1TSHRPOLBLMNA
SCHEMBL8680473 0.84 CA1 (0.52) MAPTHTT
SCHEMBL2981524 0.83 HSP90AA1 (0.43) L3MBTL1RAB9ANPC1MEN1ALDH1A1
SCHEMBL25984931 0.83 PARP1 (0.58) CES2CES1
SCHEMBL8324608 0.82 CYSLTR1 (0.49) L3MBTL1SMN1; SMN2TP53RAB9ANPC1
SCHEMBL21280074 0.82 HSP90AA1 (0.42) TP53RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416256-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARAMCEUTICA NV (BE) 2023-12-28 US disclosed
WO-2013083991-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY IMPERIAL INNOVATIONS LIMITED (GB) 2013-06-13 WO disclosed
EP-1112274-B1 CHEMILUMINESCENT 1,2-DIOXETANES GIRI BRIJ P (US) 2009-12-09 EP disclosed
EP-2048140-A1 Deuterated chemiluminescent 1,2-dioxetanes Giri, Brij P. (US) 2009-04-15 EP disclosed
US-7422908-B2 Chemiluminescent 1,2-dioxetanes GIRI BRIJ P 2008-09-09 US disclosed
US-7422908-B2 Chemiluminescent 1,2-dioxetanes GIRI BRIJ P 2008-09-09 US disclosed
US-7416898-B2 Chemiluminescent 1,2-dioxetanes GIRI BRIJ P 2008-08-26 US disclosed
US-7416898-B2 Chemiluminescent 1,2-dioxetanes GIRI BRIJ P 2008-08-26 US disclosed
EP-1453822-A4 DEUTERIUM-BASED CHEMILUMINESCENT 1,2-DIOXETANES GIRI BRIJ P (US) 2004-11-24 EP disclosed
EP-1453822-A2 DEUTERIUM-BASED CHEMILUMINESCENT 1,2-DIOXETANES Giri, Brij P. (US) 2004-09-08 EP disclosed
US-5386017-A Can be converted to stable aryl substituted 1,2-dioxetanes which decompose when activated to produce light and carbonyl compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1995-01-31 US disclosed
EP-0254051-B1 Chemiluminescent 1,2-dioxetane compounds UNIV WAYNE STATE (US) 1994-08-31 EP disclosed
EP-0595369-A1 Alkene compounds TROPIX, INC. (US) 1994-05-04 EP disclosed
EP-0458965-A4 PROCESS FOR THE PREPARATION OF VINYL ETHERS 1993-07-28 EP disclosed
EP-0458965-A1 PROCESS FOR THE PREPARATION OF VINYL ETHERS. UNIV WAYNE STATE (US) 1991-12-04 EP disclosed
WO-1991009002-A1 PROCESS FOR THE PREPARATION OF VINYL ETHERS BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-06-27 WO disclosed
US-4983779-A Process for the preparation of vinyl ethers THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-01-08 US disclosed
US-4962192-A Chemiluminescent 1,2-dioxetane compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1990-10-09 US disclosed
US-4857652-A Chemiluminescent 1,2-dioxetane compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1989-08-15 US disclosed
EP-0254051-A2 Chemiluminescent 1,2-dioxetane compounds THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1988-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416256-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, NFRKB L3MBTL1 2176/4885SMN1; SMN2 4654/4885TP53 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.